March 01, 2022
1 minute read
We have not been able to process your request. Please try again later. If you continue to have this problem, please contact [email protected]
Healio’s most-viewed neurology stories in February highlight potential dangers of marijuana to brain health, FDA expanding indication for hemorrhage detection device and NIH grant to research company biotechnology.
AHA: Effects of marijuana on brain health, function still unclear
In a new statement, the American Heart Association presented scientific evidence that challenges the belief that marijuana is harmless and underscores uncertainty about the drug’s effects on brain health. Read more.
FDA gives pediatric indication to device that detects traumatic brain hemorrhage
The FDA has granted an expanded indication for Infrascanner, a hand-held device used to detect traumatic supratentorial hematomas in adults, to now include pediatric patients ages 2 and older. Read more.
NIH awards $1.8 million to biotech company for neurodegenerative disease research
The National Institute of General Medical Sciences, a division of the NIH, has awarded Integrated Micro-Chromatography Systems Inc. $1.8 million for Phase 2 of its Accelerated Small Business Innovation Research Grant, according to a statement. Read more.
Interest from older Americans in Aduhelm is limited despite publicity and FDA approval
According to the results of a survey published in Open JAMA Network. Read more.
Revised criteria for Creutzfeldt-Jakob disease improve diagnosis
According to a European study published in Open JAMA Network. Read more.